Charles Divita III - 27 Feb 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 27 Feb 2022
Net transactions value: -$256,592
Form type: 4
Filing time: 03 Mar 2026, 16:09:31 UTC
Next filing: 12 Jun 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
DIVITA CHARLES III	CHIEF EXECUTIVE OFFICER, Director	C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK	/s/ Adam C. Vandervoort, Attorney-in-Fact	03 Mar 2026	0001347535

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+169,107	+84%		370,143	27 Feb 2022	Direct	F1
transaction	TDOC	Common Stock	Options Exercise		+7,864	+2.1%		378,007	27 Feb 2026	Direct	F2
transaction	TDOC	Common Stock	Sale	$256,592	-50,145	-13%	$5.12	327,862	02 Mar 2026	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-169,107	-33%	$0.000000	338,215	27 Feb 2026	Common Stock	169,107		Direct	F1, F4
transaction	TDOC	Performance Stock Units	Award	$0	+23,591		$0.000000	23,591	27 Feb 2026	Common Stock	23,591		Direct	F5, F6, F7
transaction	TDOC	Performance Stock Units	Options Exercise	$0	-7,864	-33%	$0.000000	15,727	27 Feb 2026	Common Stock	7,864		Direct	F2, F8
transaction	TDOC	Restricted Stock Units	Award	$0	+692,041		$0.000000	692,041	01 Mar 2026	Common Stock	692,041		Direct	F9, F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4	On March 1, 2025, the reporting person was granted 507,322 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. The reporting person's previous Form 4 filing incorrectly listed the number of restricted stock units granted as 507,332 instead of 507,322 due to a typo which has been corrected in this Form 4.
F5	Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
F6	Performance award amount determined based on metrics in respect of the issuer's 2025 financial results.
F7	The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F8	On March 1, 2026, the reporting person earned 23,591 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F9	Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F10	One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.